Superiority of Rituximab Over Mycophenolate Mofetil in the Treatment of Pemphigus Vulgaris: A Step Further in Its Approval as a First-Line Treatment?

被引：0
作者：
Lemieux, Alexandre [1 ]
Saber, Melissa [1 ]
Cote, Benoit [1 ]
机构：
[1] Ctr Hosp Univ Montreal, Serv Dermatol, Dept Med, 1000 Rue St Denis, Montreal, PQ, Canada
来源：
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 2022年 / 26卷 / 01期
关键词：
pemphigus; rituximab; mycophenolate mofetil; treatment; THERAPY;
D O I：
10.1177/12034754211035098
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [21] Comparison of CD4 Counts with Mycophenolate Mofetil versus Methotrexate from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
    Kong, Christina L.
    Kelly, Nicole K.
    Sundararajan, Miel
    Rathinam, S. R.
    Gonzales, John A.
    Thundikandy, Radhika
    Vedhanayaki, Rajesh
    Kanakath, Anuradha
    Murugan, Bala
    Thuy Doan
    Goldstein, Debra
    Al-Dhibi, Hassan A.
    Acharya, Nisha R.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (01) : 198 - 202
  • [22] Rituximab as first-line treatment for the management of adult patients with non-severe hemophiliaA and inhibitors
    Lim, M. Y.
    Nielsen, B.
    Lee, K.
    Kasthuri, R. S.
    Key, N. S.
    Ma, A. D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (06) : 897 - 901
  • [23] Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma
    Okamura, Ikue
    Imai, Hisao
    Mori, Keita
    Ogura, Kazuto
    Isoda, Atsushi
    Mihara, Keichiro
    Matsumoto, Morio
    Saito, Ryusei
    Takahashi, Toshiaki
    Ikeda, Takashi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (01) : 46 - 51
  • [24] Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma
    Cencini, Emanuele
    Fabbri, Alberto
    Schiattone, Luana
    Bartalucci, Giulia
    Bocchia, Monica
    LEUKEMIA & LYMPHOMA, 2015, 56 (10) : 2997 - 2998
  • [25] First-line treatment of TAFRO syndrome with rituximab: a case report and literature review
    Servati, Salar
    Mohammadi, Ida
    Firouzabadi, Shahryar Rajai
    ANNALS OF HEMATOLOGY, 2025, : 3035 - 3046
  • [26] A low-dose rituximab regimen for first-line treatment of acquired haemophilia A
    Hunt, Stewart
    Robertson, Jeremy
    Conn, Jason
    Casey, John
    Royle, Jane
    Collins, Joel
    Hourigan, Matthew
    Richmond, Joshua
    Yang Wang, Tzu
    Mills, Anthony
    Mason, Jane
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 108 (01) : 28 - 33
  • [27] Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma
    Gwladys Claustre
    Coralie Boulanger
    Frédéric Maloisel
    Nelly Etienne-Selloum
    Luc-Matthieu Fornecker
    Eric Durot
    Florian Slimano
    Véronique Graff
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 1883 - 1893
  • [28] Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphoma
    De la Cruz Vicente, Fatima
    Carrillo-Cruz, Estrella
    Sole Rodriguez, Maria
    Marin Niebla, Ana
    Martino Galiana, Maria Luz
    Falantes Gonzalez, Jose
    Montero Cuadrado, Isabel
    Gonzalez Campos, Jose
    Espigado Tocino, Ildefonso
    Rios-Herranz, Eduardo
    Antonio Perez-Simon, Jose
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (06) : 469 - 475
  • [29] Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma
    Claustre, Gwladys
    Boulanger, Coralie
    Maloisel, Frederic
    Etienne-Selloum, Nelly
    Fornecker, Luc-Matthieu
    Durot, Eric
    Slimano, Florian
    Graff, Veronique
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (05) : 1883 - 1893
  • [30] Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma
    Ikue Okamura
    Hisao Imai
    Keita Mori
    Kazuto Ogura
    Atsushi Isoda
    Keichiro Mihara
    Morio Matsumoto
    Ryusei Saito
    Toshiaki Takahashi
    Takashi Ikeda
    International Journal of Hematology, 2015, 101 : 46 - 51
12345